Optimise Collection Mix

Apheresis collection from single donors is sometimes preferred as the platelet preparation methods than the pooling of whole-blood-derived components. One of the drivers for this choice is the potentially higher risk of pathogen transmission through pooled products. By eliminating or reducing this risk, the INTERCEPT™ Blood System provides a more favourable risk assessment for whole-blood-derived products, allowing for an optimised product mix taking into account donor availability and cost constraints.